# Efficacy of Hyperbaric Oxygen Therapy (HBOT) in New-onset Type-1 Diabetes Mellitus

> **NCT04412200** · NA · RECRUITING · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 36 (estimated)

## Conditions studied

- T1DM

## Interventions

- **DEVICE:** Hyperbaric oxygen chamber (HBOC)

## Key facts

- **NCT ID:** NCT04412200
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-06-01
- **Primary completion:** 2024-11
- **Final completion:** 2026-05
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04412200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04412200, "Efficacy of Hyperbaric Oxygen Therapy (HBOT) in New-onset Type-1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04412200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*